Scar Prevention

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Lumenis
LumenisAustralia - Chatswood
1 program
Lumenis UltraPulse single fractional CO2 laser treatment thin skinN/A1 trial
Active Trials
NCT01826942Terminated10Est. Mar 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
LumenisLumenis UltraPulse single fractional CO2 laser treatment thin skin

Clinical Trials (1)

Total enrollment: 10 patients across 1 trials

NCT01826942LumenisLumenis UltraPulse single fractional CO2 laser treatment thin skin

Scar Prevention Using Fractional Carbon Dioxide Laser Treatment

Start: Jan 2013Est. completion: Mar 201310 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space